ES2053872T3 - Derivados de fibrina o fibrinogeno, procedimiento para su preparacion y su empleo. - Google Patents

Derivados de fibrina o fibrinogeno, procedimiento para su preparacion y su empleo.

Info

Publication number
ES2053872T3
ES2053872T3 ES89110250T ES89110250T ES2053872T3 ES 2053872 T3 ES2053872 T3 ES 2053872T3 ES 89110250 T ES89110250 T ES 89110250T ES 89110250 T ES89110250 T ES 89110250T ES 2053872 T3 ES2053872 T3 ES 2053872T3
Authority
ES
Spain
Prior art keywords
fibrin
fibrinogen
derivatives
employment
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89110250T
Other languages
English (en)
Inventor
Thomas Dr Stief
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2053872T3 publication Critical patent/ES2053872T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

SE DESCRIBEN DERIVADOS OXIDADOS DE FIBRINA O DE PRODUCTOS DE ESCISION DE FIBRINA O FIBRINOGENO O SECUENCIAS PARCIALES DE LOS MISMOS. TAMBIEN SE DESCRIBEN PROCESOS PARA SU OBTENCION, ASI COMO SU USO COMO MEDICAMENTOS PARA DIAGNOSIS O COMO AGENTE AFIN.
ES89110250T 1988-06-11 1989-06-07 Derivados de fibrina o fibrinogeno, procedimiento para su preparacion y su empleo. Expired - Lifetime ES2053872T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3819923A DE3819923A1 (de) 1988-06-11 1988-06-11 Fibrin(ogen)derivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
ES2053872T3 true ES2053872T3 (es) 1994-08-01

Family

ID=6356348

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89110250T Expired - Lifetime ES2053872T3 (es) 1988-06-11 1989-06-07 Derivados de fibrina o fibrinogeno, procedimiento para su preparacion y su empleo.

Country Status (7)

Country Link
US (2) US5376631A (es)
EP (1) EP0346741B1 (es)
JP (1) JPH0236200A (es)
AT (1) ATE85623T1 (es)
AU (1) AU621373B2 (es)
DE (2) DE3819923A1 (es)
ES (1) ES2053872T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE912528A1 (en) * 1990-07-19 1992-01-29 Scripps Clinic Res Inhabition of mac-1 receptor binding fibrinogen using d30¹homologs
AU644205B2 (en) * 1990-08-23 1993-12-02 New York Blood Center, Inc., The Assays using a soluble fibrin-like monomer
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
EP1130031A1 (en) * 2000-02-25 2001-09-05 Universitair Medisch Centrum Utrecht Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity
EP1328289B1 (de) * 2000-10-20 2008-09-03 Hamburger Stiftung zur Förderung von Wissenschaft und Kultur Oxidierte proteine und deren biologische und therapeutische aktivität sowie diagnostische verwendung über die hemmung der interaktion zwischen oxidierten proteinen und cd36
JP6042106B2 (ja) * 2011-06-10 2016-12-14 株式会社ファンペップ メチオニン・スルホキシドを含む新規ポリペプチド
EP3279333B1 (en) 2015-03-30 2019-09-18 National University Corporation Kobe University Measurement method for unbound bilirubin in blood sample

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979506A (en) * 1974-10-11 1976-09-07 Pierce Chemical Company Radioactive compounds for labeling proteins
US4455290A (en) * 1981-04-02 1984-06-19 Research Corporation Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1
US4427646A (en) * 1981-04-02 1984-01-24 Research Corporation Use of radiolabeled peptide derived from crosslinked fibrin to locate thrombi in vivo
DE3722082A1 (de) * 1987-07-03 1989-01-12 Behringwerke Ag Verfahren zur bestimmung der aktivitaet von serinproteasen oder serinproteaseinhibitoren

Also Published As

Publication number Publication date
US5427918A (en) 1995-06-27
EP0346741B1 (de) 1993-02-10
US5376631A (en) 1994-12-27
DE58903500D1 (de) 1993-03-25
ATE85623T1 (de) 1993-02-15
EP0346741A3 (en) 1990-05-16
JPH0236200A (ja) 1990-02-06
DE3819923A1 (de) 1989-12-21
AU621373B2 (en) 1992-03-12
EP0346741A2 (de) 1989-12-20
AU3619389A (en) 1989-12-14

Similar Documents

Publication Publication Date Title
ES529020A0 (es) Procedimiento para la obtencion de preparados para realizar diagnosticos medicos.
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
DK154528C (da) Fremgangsmaade til fremstilling af farmaceutiske, kosmetiske eller diagnostiske praeparater
ES492310A0 (es) Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas
AR220004A1 (es) Procedimiento para la preparacion de derivados de 4,4-dimetil-2-imidazolidinona
DE3483085D1 (de) Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel.
AR215172A1 (es) Medios diagnosticos para la identificacion de hidroperoxidos
AR216829A1 (es) Procedimiento para la industrializacion de sangre y restos de origen animal,inclusive huesos
AR207877A1 (es) Procedimiento para la produccion de trasplantes heterologos de arterias
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
DE3751842D1 (de) Modifizierter, menschlicher Gewebeplasminogenaktivator und seine Herstellung
DE3689943D1 (de) Degradierte Spezies eines Gewebeplasminogenaktivators, pharmazeutische Zubereitung und Verfahren zur Herstellung derselben.
ES2072251T3 (es) Composiciones y metodos para la sintesis y ensayo de enquefalinasa.
ES2053872T3 (es) Derivados de fibrina o fibrinogeno, procedimiento para su preparacion y su empleo.
AR228011A1 (es) Procedimiento para la preparacion de derivados sustituidos de 2,5,5,8a-tetrametil-1,2,3,4,4a,5,6,7,8,8a-decahidronaftaleno-1-spiro-2'-(4',6',7'-sustituido-2',3'-dihidrobenzofurano)
MX5256E (es) Procedimiento para la preparacion de derivados de 20,21-dinoreburnamenina
AR225276A1 (es) Procedimiento para la preparacion de 1,1,1,2-tetrafluoroetano
ES542061A0 (es) Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas
NL7902232A (nl) Wegwerpprodukt zoals een luier, sanitaire doek of dergelijke en werkwijze ter vervaardiging daarvan.
AR225415A1 (es) Procedimiento para la obtencion de nuevos derivados de pirido(2,1-b)quinazolina
MX6933E (es) Procedimiento biologico para preparar una mezcla de androsta-1,4-dien-3,17-diona y androst-4-en-3,17-diona
MX6009E (es) Procedimiento para la preparacion de tetrahidro-1,3,5-tiadiazin-4-onas
ES487818A0 (es) Procedimiento para la preparacion de nuevas sustancias analogas de prostaciclina
AR225134A1 (es) Procedimiento para la preparacion de acidos 3,7-disustituidos-3-cefem-4-carboxilicos
AR230835A1 (es) Procedimiento para la obtencion de derivados de 2,1,3-tiadiazin-4-ona-2,2-dioxido

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 346741

Country of ref document: ES